Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Cook Wealth LLC

Cook Wealth LLC increased its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 19.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,386 shares of the technology company’s stock after purchasing an additional 1,984 shares during the quarter. Cook Wealth LLC’s holdings in Simulations Plus were worth $345,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp boosted its stake in Simulations Plus by 4.7% during the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company’s stock worth $20,503,000 after purchasing an additional 28,953 shares during the last quarter. Geode Capital Management LLC boosted its position in Simulations Plus by 4.4% during the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after acquiring an additional 18,924 shares during the last quarter. Tributary Capital Management LLC boosted its position in Simulations Plus by 21.7% during the fourth quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company’s stock worth $11,047,000 after acquiring an additional 70,526 shares during the last quarter. Royce & Associates LP grew its stake in Simulations Plus by 28.8% during the 3rd quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after acquiring an additional 53,092 shares in the last quarter. Finally, Congress Asset Management Co. raised its holdings in Simulations Plus by 22.5% in the 3rd quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock valued at $6,613,000 after acquiring an additional 37,914 shares during the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Price Performance

NASDAQ SLP opened at $34.32 on Monday. The stock has a market capitalization of $689.49 million, a P/E ratio of 85.80 and a beta of 0.82. The firm’s 50-day moving average is $30.46 and its two-hundred day moving average is $32.50. Simulations Plus, Inc. has a 12 month low of $24.00 and a 12 month high of $51.22.

Analyst Upgrades and Downgrades

SLP has been the subject of a number of analyst reports. KeyCorp upped their price target on Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. William Blair restated an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. BTIG Research reduced their price target on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday, October 24th. StockNews.com lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. Finally, Stephens initiated coverage on shares of Simulations Plus in a research note on Friday, November 15th. They set an “overweight” rating and a $39.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $49.40.

Insider Activity

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $31.76, for a total value of $635,200.00. Following the completion of the transaction, the director now directly owns 3,442,584 shares of the company’s stock, valued at $109,336,467.84. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 19.40% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.